MarketInOut Stock Screener Log In | Sign Up

Mayne Pharma Group Ltd

Healthcare • Medical Distribution • Quote as of 10/28/2026 16:10
Mayne Pharma Group Ltd stock price and volume chart

Company Profile

IndustryMedical Distribution
SectorHealthcare
Market Capitalization203.09 mln
Float70.13 mln
Earnings Date02/24/2027

EPS

0.31
Marginal

P / E

8.29
Undervalued

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.59
Likely reliable

Relative Strength

47 / 100
In line with market

Debt / Equity

0.11
Very low leverage

Business Description

Mayne Pharma Group Limited is an Australian pharmaceutical company that develops and sells medicines focused on women's health and skin conditions across markets including the US, Canada, Europe, Asia, and beyond. The company also manufactures and develops drug products for other businesses under contract. Founded in 2005 and headquartered in Salisbury, South Australia, it was previously called Halcygen Pharmaceuticals Limited before adopting its current name in 2010.

Key Fundamentals

EPS0.31
P/E8.29
ROE6.59
RPS4.80
ROIC-6.88
ROA2.56
Interest Cover-10.47
EBITDA, mln105
EV / EBITDA2.19
EV / EBIT5.59
Revenue, mln384
EV / Revenue0.60

Quote Details

Last 2.63
Change 0.21 (8.68%)
Open 2.51
Volume 109,280
Turnover 287,406
Average Volume 112,644

Financial Ratios

Pre-Tax Profit Margin9
Leverage Ratio2.33
Current Ratio1.31
Price / Book0.61
Price / Cash Flow12.90
Price / Free Cash Flow24.74
Debt / Equity0.11
Price / Sales0.66
PEG Ratio2.52

Financial Strength

Altman Z-Score-0.62
Piotroski F-Score 6 / 9
Beneish M-Score-2.59
Price to Intrinsic Value0.79

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.54% 84 / 100   
1 Month -7.07% 40 / 100   
2 Months -2.95% 48 / 100   
6 Months -6.41% 48 / 100   
1 Year -56.74% 13 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog